Format

Send to

Choose Destination
J Neuroimmunol. 2012 Feb 29;243(1-2):73-80. doi: 10.1016/j.jneuroim.2011.12.010. Epub 2012 Jan 14.

Upregulation of IL-17, but not of IL-9, in circulating cells of CIS and relapsing MS patients. Impact of corticosteroid therapy on the cytokine network.

Author information

1
Unité de Neurochimie, Institute of Neuroscience, Avenue Mounier, 53 (BP 53.02), Belgium.

Abstract

The concomitant production of IL-17A and IL-9, both Th17 cytokines, has not been compared in MS patients. We show that IL-17A but not IL-9 expression by CD3(+) cells was increased during a MS relapse. Co-expression of IL-17A and IL-9 was marginal. In addition to Th1 and Th2 cytokines, IL-17A, IL-6 and IL-23p19 were down-regulated by ivMP, but Foxp3 was not, while an increase in IL-10, TGF-β1 and IL-27p28 mRNA was observed. This change in the Th17, Treg and IL-10 balance could be an additional mechanism by which corticosteroids shorten the duration of a MS relapse and promote recovery.

PMID:
22245284
DOI:
10.1016/j.jneuroim.2011.12.010
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center